Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 701–800 of 933
Carr, M. M., Ellis, J. D., Saules, K. K., & Ledgerwood, D. M. (2022) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001581 · Cited by 3
Neuromarkers in addiction: definitions, development strategies, and recent advances
Harp, N. R., Wager, T. D., & Kober, H. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02766-2 · Cited by 4
“…disorders are frequently seen in adolescents who misuse substances (Kroll et al. 2020); and lifetime prevalence of mood and anxiety disorders among adults with at least one SUD are 40.9% and 29.9%, respectively (Conway et al. 2006), much higher than expected in individuals with no SUDs.”
InfluentialMéndez, S. B., & Salazar‐Juárez, A. (2024) · Developmental Psychobiology · doi:10.1002/dev.22493 · Cited by 3
Heinz, M. V., Lekkas, D., Abreu, V., Lee, C. M., Marsch, L. A., & Jacobson, N. C. (2024) · npj Mental Health Research · doi:10.1038/s44184-024-00086-7 · Cited by 2
“Consequently, thetotalscorevariesfrom0to27,withathresholdof10oftenusedtoindicate MDD. ThePHQ-9showsrobustconstructandcriterionvalidity;asum-mativescoreof10orhigherdisplaysan0.”
InfluentialValente, L., Freitas, A., & Gonçalves‐Pinho, M. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2515027 · Cited by 2
“We found that anxiety disorders were more common among hospitalizations of patients with a diagnosis of tobacco use disorder and is known that lifetime rates of anxiety disorders are higher among women (Conway et al., 2006).”
Kurowecki, D., & Godbout, J. (2014) · University of Ottawa Journal of Medicine · doi:10.18192/uojm.v4i1.1039 · Cited by 2
“Contrary to popular belief, the main causes of early death are not drug overdose or suicide, but rather, preventable illnesses such as cardiovascular disease, diabetes, and HIV/AIDS [1,3,5-7].”
BackgroundKamarajan, C., Pandey, A. K., Chorlian, D. B., Meyers, J. L., Kinreich, S., Pandey, G., de Viteri, S. S., Zhang, J., Kuang, W., Barr, P. B., et al. (2023) · Behavioral Sciences · doi:10.3390/bs13050427 · Cited by 4
Avoidance as an Explanatory Mechanism for Poor Outcomes in Treatment for Substance Use Disorders
Oakland, A. (2015) · Lincoln (University of Nebraska) · Cited by 4
A Person-centered Approach to Diagnosis and Care for Bipolar Disorder and Alcoholism
Salloum, I. M. (2014) · The International Journal of Person Centered Medicine · doi:10.5750/ijpcm.v3i3.418 · Cited by 2
Epidemiology of Psychiatric Illness
Blazer, D. G., & Hybels, C. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_32 · Cited by 2
“adults 18 years and older, AUDADIS-IV (DSM-IV) ( 8 ); LT, lifetime.”
BackgroundBullying, Victimization, Depression, And Substance Use: Sex As A Possible Complicating Factor
Natishyn, M. C. (2013) · UTA ResearchCommons (University of Texas Arlington) · Cited by 2
Clinical Implications of Epidemiologic Data for Diagnosis and Treatment of Psychiatric Comorbidity
Samet, S., & Hasin, D. S. (2008) · Psychiatric Annals · doi:10.3928/00485713-20081101-10 · Cited by 3
Brand, A., Guillod, L., Habersaat, S., Panchaud, E., Stéphan, P., & Urben, S. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12331 · Cited by 5
Recent Advances in the Studies of Anxiety Disorders—An Overview
Kaiya, H., Tsuchida, H., Suyama, H., & Kaneko, Y. (2013) · Anxiety Disorder Research · doi:10.14389/adr.4.20 · Cited by 2
Complex Comorbidity of Substance Use Disorders with Anxiety Disorders: Diagnosis and Treatment
Yılmaz, O., & Dılbaz, N. (2016) · InTech eBooks · doi:10.5772/66247 · Cited by 5
“[4] 43,093 Americans NESARC DSM-IV (AUDADIS) Prevalence of any AD is higher among individuals with DUD than the normal population, 29.”
BackgroundWhiteley, L., Warner, J. L., Ahuja, M., Curtis, V., Kessimian, M., Ryoo, H.-J., & Brown, L. K. (2017) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-017-9815-2 · Cited by 3
Alim, T. N., Kumari, S., Adams, L. B., Cyr, D. A. S., Tulin, S. J., Song, E. C., Hipolito, M. M. S., Peterson, L., & Lawson, W. B. (2017) · Clinical Psychiatry · doi:10.21767/2471-9854.100042 · Cited by 2
Hazardous alcohol consumption in non-aboriginal male inmates in New South Wales
Field, C. (2018) · International Journal of Prisoner Health · doi:10.1108/ijph-11-2016-0068 · Cited by 4
Konkel, R. H., Harris, M. N., & Hoffman, C. Y. (2022) · Journal of Drug Issues · doi:10.1177/00220426211073912 · Cited by 3
Family and Adoption Studies of Substance Use
Stallings, M. C., Kent, K. R., & Frieser, M. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-95350-8_5 · Cited by 3
Aitken, B., Downey, L. A., & Hayley, A. C. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2089992 · Cited by 3
Baginski, B. N., Byrne, K. A., Demosthenes, L. D., & Roth, P. (2022) · Substance Abuse Research and Treatment · doi:10.1177/11782218221115583 · Cited by 5
Exposure Therapy when Patients Present with Comorbid Substance Use Disorders
Harvey, L. R., Saraiya, T. C., Mills, K. L., Brown, D. G., Jarnecke, A. M., Back, S. E., & Stapinski, L. A. (2022) · Springer eBooks · doi:10.1007/978-3-031-04927-9_5 · Cited by 2
Mahoney, J. J., Bryant, K. R., & Haut, M. W. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_32 · Cited by 2
Opiate Use and Abuse, History of
Heyman, G. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.45023-3 · Cited by 2
Kamarajan, C., Pandey, A. K., Chorlian, D. B., Meyers, J. L., Kinreich, S., Pandey, G., de Viteri, S. S., Zhang, J., Kuang, W., Barr, P. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.30.522330 · Cited by 2
“…the past studies have shown mixed findings for the harm avoidance subscale of the TPQ in predicting AUD/SUD and risk [38,137], some of the latter studies have associated these internalizing traits with harmful use of alcohol and other substances [138,139] and with risk to develop AUD [140-142].”
ResultNon-medical use of prescription drugs
Bettinardi–Angres, K., Bickelhaupt, E. E., & Bologeorges, S. (2012) · The Nurse Practitioner · doi:10.1097/01.npr.0000415242.77611.15 · Cited by 1
“There are grassroots movements along with many legislators trying to educate the public about this problem, but the NP, as both a trusted caregiver and prescriber, can make a signifi cant difference with knowledgeable assessments and referrals that help patients discontinue NMUPD.”
BackgroundInfluentialTrachsel, M., Chochinov, H. M., & Irwin, S. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-84702-5.00026-9 · Cited by 1
Is Obsessive–Compulsive Disorder Preventive Against Addiction?
Tan, O. (2021) · The Journal of Neurobehavioral Sciences · doi:10.4103/jnbs.jnbs_15_21 · Cited by 4
Homayoun, B., Hinkle, A. J., Clark, I. A., Mounasamy, V., & Sambandam, S. N. (2025) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-025-05827-7 · Cited by 3
Mental health behaviors and suicide risk among White and Black adults with Opioid Use Disorder
Szlyk, H. S., Lew, D., Li, X., Filiatreau, L. M., Peoples, J. E., Kasson, E. M., & Cavazos‐Rehg, P. A. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118283 · Cited by 1
The persistent effects of exposure to a predator odor stressor on sensitivity to alcohol
Tyler, R. E., Bluitt, M. N., Voorhies, K. V., Liu, W., Magee, S. N., Pitrolo, E. R., Cordero, V. L., Ornelas, L. C., Krieman, C. G., Bender, B. N., et al. (2025) · Addiction Neuroscience · doi:10.1016/j.addicn.2025.100230 · Cited by 2
“Because men may drink more for reward vs. relief relative to women [83–86], these findings may have identified a novel vulnerability factor by which males escalate drinking following traumatic stress.”
Barbaglia, G., Calafell, J. M., Angulo-Brunet, A., Alcaraz, S., Bartrolí, M., Mestre-Pintó, J. I., & the Methadone Study Group (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2557191 · Cited by 1
“This project aimed to establish a clinical and pharmacogenetic model to predict patient satisfaction with methadone as a treatment for OUD.”
InfluentialZaha, A. A., Comșa, A. L., Zaha, D. C., & Vesa, C. M. (2025) · Healthcare · doi:10.3390/healthcare13192543 · Cited by 2
“Anxiety was a predictor of substance abuse in women in other studies and a common finding together with depressive disorders, contrary to our results [16,17].”
Lalanne, L., Lutz, P.-É., Caparros-Roissard, A., Ruppert, É., Waeckerle, G., Scherer, C., Oster, F., Brand, C., Henck, S., Soavelo, H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093358 · Cited by 2
Rosário, B. D. A., Lemes, J. A., Ceneviva, R., Ribeiro, D. A., & Viana, M. D. B. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115898 · Cited by 2
Ware, O. D., Geiger, G. R., & Cano, M. T. (2026) · PLOS mental health. · doi:10.1371/journal.pmen.0000337 · Cited by 2
“Lifetime cocaine use disorder prevalence among individuals with a mood disorder is 6.5% and 5.4% among individuals with an anxiety disorder [12].”
InfluentialThe Treatment of Co-Occurring Psychiatric and Substance Use Disorders: New Findings and Unmet Needs
Brady, K. T. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260096 · Cited by 1
Votaw, V. R., Rosen, R. S., Peckham, A., London, Z., Philpotts, L. L., Weiss, R. D., McHugh, R. K., & Streck, J. M. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2026.2638194 · Cited by 1
“Co-occurring psychiatric disorders are highly prevalent among individuals with opioid use disorder (OUD) (Conway et al., 2006; Grella et al., 2009; Strain, 2002).”
Wilson, A. D., Cherry, J., Gicas, K. M., & Wojtowicz, M. A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346562 · Cited by 1
“The sex gap in the proportion of individuals with substance use disorders is narrowing [54] and women may be particularly at risk of experiencing higher rates of psychiatric disorders co-occurring with substance use disorders, which further complicates treatment [55].”
Williams, J., Bretteville‐Jensen, A. L., & Rose, C. D. (2026) · Journal of Health Economics · doi:10.1016/j.jhealeco.2026.103162 · Cited by 2
The Role of Agomelatine in the Treatment of Anxiety Disorders
Berardis, D. D., Serroni, N., Cavuto, M., Fornaro, M., Martinotti, G., Moschetta, F. S., & Giannantonio, M. D. (2013) · Springer eBooks · doi:10.1007/978-81-322-0825-9_21 · Cited by 1
Willis, O. J., Mann, R., Strıke, C., Brands, B., & Khenti, A. (2012) · Texto & Contexto - Enfermagem · doi:10.1590/s0104-07072012000500020 · Cited by 1
Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors
Gonçalves, C. L., Furlanetto, C. B., Valvassori, S. S., Bavaresco, D. V., Varela, R. B., Budni, J., Quevedo, J., & STRECK, E. L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9617-1 · Cited by 1
The clinical challenge of comorbid bipolar disorder and substance use disorder
Salloum, I. M. (2006) · The Psychiatric times · Cited by 1
El cerebro social y místico en el paciente dependiente de sustancias
Franco, G., Migliaro, M., Molina, L., Méndez‐Díaz, M., Ruiz‐Contreras, A. E., Morelos, J. C., Herrera-Solís, A., & Prospero-Garcia, O. E. (2021) · PSICUMEX · doi:10.36793/psicumex.v11i1.393 · Cited by 2
Differences in Co-occurring Disorder Timing, Onset, and Sequence by Gender
van Draanen, J., & Upchurch, D. M. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-022-00799-w · Cited by 1
“Given the known gendered differences in disorders (Conway et al., 2006; Grant & Weissman, 2007; Grella & Joshi, 1999; Kessler, Chiu, et al., 2005), the order of disorder development in COD may be a critical phenomenon to attend to, as developing a “gender atypical” disorder may be an even more stressful experience tha…”
BackgroundMental health emergency department visits: An exploration of case definitions in North Carolina
LeMasters, K. H., Cox, M. E., Fliss, M. D., Seibert, J., Brown, C., & Proescholdbell, S. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.04.053 · Cited by 2
Group Therapy for Substance Use Disorders
McHugh, R. K., Park, S., & Weiss, R. D. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_42 · Cited by 1
Ahmadi, J., Bazrafshan, A., Sahraian, A., Jalali, S., Fakhermanesh, M., & Hooshyari, Z. (2022) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_297_21 · Cited by 1
“Anxiety is reported as one of the comorbid psychiatric disorders of MA dependence, in the range of 25%[8] to 76% [15]; they experience a high level of anxiety that drives them to seek illegal drugs [16].”
BackgroundExposure Therapy in the Treatment of Substance Use Disorders
McHugh, R. K., Kosiba, J. D., & Chase, A. R. (2022) · Springer eBooks · doi:10.1007/978-3-031-04927-9_14 · Cited by 1
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Altemus, M. M., Bogen, D. L., Famy, C. S., Pearlstein, T. B., Misra, D. P., Reynolds, S. K., & Perel, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00052-1 · Cited by 3
Tatari, F., Farnia, V., Lalehgni, F., Moradi, A., Radmehr, F., Davarinejad, O., Hookari, S., Salemi, S., Golmohammadi, F., & Alikhani, M. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2144508 · Cited by 1
“Recent national epidemiologic data indicate that 41.6% of the adults with amphetamine use disorders and 35.7% of those with cocaine use disorders have a lifetime history of depression (Conway et al., 2006).”
BackgroundInfluentialMartino, G. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_19 · Cited by 1
Katmer, A. N., & Hamamcı, Z. (2023) · Journal for the Education of Gifted Young Scientists · doi:10.17478/jegys.1240948 · Cited by 2
Benzodiazepine Dose Intensity among Patients Concurrently Prescribed Buprenorphine in Rhode Island
Borrelli, E. P., Bratberg, J. P., Hallowell, B. D., & Kogut, S. J. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2205492 · Cited by 1
“One analysis of the National Epidemiologic Survey on Alcohol and Related Conditions from 2001 to 2002 found that approximately 36.3% of patients with OUD had an anxiety disorder compared to only 16.2% of the general population (Conway et al., 2006).”
MethodInfluentialRao, R., Ganesh, R., Kishore, K., Madan, I., Khandpal, B., & Sharma, C. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176241236899 · Cited by 2
“About 25.4% ( n = 53) of the participants reported”
InfluentialMéndez, S. B., & Salazar‐Juárez, A. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10358 · Cited by 1
McHugh, R. K., Bailey, A. J., & Yusufov, M. (2024) · CBT: science into practice · doi:10.1007/978-3-031-62971-6_9 · Cited by 2
Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_29 · Cited by 2
Clinical characterisation of dual depression and association with bipolarity features
Barbuti, M., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S. N., Young, A. H., Vieta, E., Perugi, G., & Maremmani, I. (2024) · Heroin addiction and related clinical problems · doi:10.62401/2531-4122-2024-43 · Cited by 1
Lippard, E., Kirsch, D. E., Le, V., Lee, S.-H., Bibb, N., Meek, K., Kosted, R., Huffman, A., Almeida, J., Fromme, K., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1549295 · Cited by 1
Psychological Distress Trajectories in Residential Alcohol and Other Drug Treatment
Hatton, E. L., Kelly, P. J., Robinson, L. D., Beck, A. K., Lee, M. L., Stirling, R., Mullaney, L., Campbell, M., & Larance, B. (2025) · Drug and Alcohol Review · doi:10.1111/dar.14099 · Cited by 1
Assessment Strategies for Substance Use Disorders
Mancini, M. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5357-4_4 · Cited by 1
Proportionality Review in EU Gambling Law
Planzer, S. (2013) · Studies in European economic law and regulation · doi:10.1007/978-3-319-02306-9_9 · Cited by 1
Fluoxetine: Pharmacological and Computational Study
Siddiqui, N., Alam, M. S., Alam, O., Andalip, & Azad, B. (2011) · Cited by 1
Comorbid Anxiety and Alcohol or Substance Use Disorders: An Overview
Bartoli, F., Carretta, D., Clerici, M., & Carrà, G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_91 · Cited by 2
MacLean, R. R., & Sofuoglu, M. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0212-0 · Cited by 2
Psicopatologia desenvolvimental e dependência de opioides
Ferreira, S. C. M. (2018) · International Journal of Developmental and Educational Psychology Revista INFAD de psicología · doi:10.17060/ijodaep.2018.n2.v1.142 · Cited by 1
La pratique clinique des traitements de substitution à l’héroïne et les alternatives
Laqueille, X. (2016) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30674-0 · Cited by 1
“Ces études permettent d’intégrer les thérapeutiques substitutives parmi les autres propositions thérapeutiques de l’héroïnomanie à côté des traitements de sevrage et des communautés thérapeutiques [14, 55].”
BackgroundSchweinhart, A. M., Cargill, V. A., Brady, K. T., Hall, K. L., Spencer, E. A., & Clayton, J. A. (2019) · Journal of Women s Health · doi:10.1089/jwh.2019.29027.pcss · Cited by 1
“2 times as likely to have an anxiety disorder.(44,45) ‘‘The relationship between childhood adversity and addiction is stronger in women than it is in men.”
Substance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · ODU Digital Commons (Old Dominion University) · Cited by 3
Troubles anxieux, troubles dépressifs, conduites suicidaires et cannabis
Dervaux, A., Carvalho, C. D., & Cottencin, O. (2020) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2020.09.015 · Cited by 4
Prevalence and risk factors for depressive symptom in methamphetamine use disorder
Liu, Z., Zhang, Y., & Yuan, T. (2021) · Stress and Brain · doi:10.26599/sab.2020.9060009 · Cited by 1
“41.6% of MUD individuals reported a lifetime history of depression [9].”
InfluentialDarlington, C. K., Compton, P. A., Teitelman, A. M., & Alexander, K. (2021) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2021.100017 · Cited by 3
Gokarakonda, S. B., Boydstun, J. M., Yilanli, M., Han, X., Kumar, N., Oliveto, A. H., & Mancino, M. J. (2022) · American Journal on Addictions · doi:10.1111/ajad.13266 · Cited by 1
Tobacco and Alcohol Use Behaviors
Hoft, N. R., Sakai, J. T., & Ehringer, M. A. (2010) · Issues in clinical child psychology · doi:10.1007/978-1-4419-5800-6_15 · Cited by 1
Duvenhage, I. (2010) · Boloka Institutional Repository (North-west University) · Cited by 1
Treatment Models for Comorbid Psychiatric and Addictive Disorders
Kassel, J. D., Heinz, A. J., Evatt, D. P., & Braun, A. R. (2010) · Wiley eBooks · doi:10.1002/9780470710449.ch35 · Cited by 3
Treatments for Offenders with Dual Diagnosis
Cohn, A. M., & Mueser, K. T. (2012) · Wiley eBooks · doi:10.1002/9781118411094.ch13 · Cited by 2
States' Early Experience in Improving Systems-Level Care for Persons with Co-Occurring Disorders
Dausey, D. J., Pincus, H. A., Herrell, J. M., & Rickards, L. D. (2007) · Cited by 1
Epidemiology of Illicit Drug Use Disorders
Compton, W. M., Lopez, M. F., Conway, K. P., & Thomas, Y. F. (2011) · Wiley eBooks · doi:10.1002/9780470976739.ch22 · Cited by 2
Self-citationStimulant use disorders and psychosis: prevalence, correlates and impacts
Sara, G. E. (2014) · The University of Queensland · doi:10.14264/uql.2015.15 · Cited by 1
“The US National Epidemiological Survey of Alcohol and Related Conditions (Conway et al., 2006) found high rates of lifetime depressive disorders (51%) and anxiety disorders (39%) in individuals with amphetamine abuse or dependence.”
BackgroundHelseth, V. (2013) · Duo Research Archive (University of Oslo) · Cited by 2
Shen, Y. F. (2015) · TSpace (University of Toronto) · Cited by 3
Academic Stress among University Students and Its Effect on Mental Health
Banu, R. P. (2015) · Shodhganga · Cited by 1
Havinga, P. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.112725525 · Cited by 2
Virtanen, S. (2021) · Helda - University of Helsinki Institutional Repository · Cited by 2
Deng, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00124-2 · Cited by 1
Morel, C., Parise, L. F., van der Zee, Y. Y., Issler, O., Cai, M., Browne, C. J., Blando, A., LeClair, K. B., Haynes, S. E., Williams, R. W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.23.581795 · Cited by 1
Tyler, R. E., Bluitt, M. N., Voorhies, K. J. V., Liu, W., Magee, S. N., Pitrolo, E. R., Cordero, V. L., Ornelas, L. C., Krieman, C. G., Bender, B. N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.30.621141 · Cited by 1
Psychiatric Disorders, utilization of mental health services and psychoactive substance use
Encrenaz, G., & MESSIAH, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Reedy, A. R. (2010) · doi:10.17077/etd.ux973d4j
“Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions.”
MethodInfluentialTrastorno por uso de sustancias y su relación con el trastorno por déficit de atención
Bustos, O. E. A. (2014) · Revista de especialidades m�dico-quir�rgicas · Cited by 2
Genes candidatos para la comorbilidad entre trastornos de ansiedad y trastornos adictivos.
Moreno, X. G. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Relationships Between Mood Disorders and Substance Abuse During Adolescence
Justo, L. P., & Calil, H. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17795-3_11
Psychodynamic Psychotherapy With Adjunctive Hypnosis for Anxiety Management and Smoking Cessation
Watkins, C., & Macfie, J. (2013) · Clinical Case Studies · doi:10.1177/1534650113493348
Wang, M., Finch, E., & Wolff, K. (2013) · Journal of Substance Use · doi:10.3109/14659891.2013.784370 · Cited by 2
“This co-morbidity has been discovered in various drugs, and has been found to be associated with negative outcomes of persistence and severity of drug use and psychiatric disorders (Conway et al., 2006; Compton et al., 2005; Glantz et al., 2009; Hasin et al., 2007; WHO, 2004).”
Background
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.